| Item Type | Name |
|
Concept
|
Stem Cell Factor
|
|
Concept
|
Myeloid Differentiation Factor 88
|
|
Concept
|
Receptor, Platelet-Derived Growth Factor beta
|
|
Concept
|
TNF Receptor-Associated Factor 1
|
|
Concept
|
Platelet-Derived Growth Factor
|
|
Concept
|
STAT5 Transcription Factor
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Granulocyte Colony-Stimulating Factor
|
|
Concept
|
TNF Receptor-Associated Factor 3
|
|
Concept
|
Lymphoid Enhancer-Binding Factor 1
|
|
Concept
|
Receptor, Platelet-Derived Growth Factor alpha
|
|
Concept
|
TNF Receptor-Associated Factor 2
|
|
Concept
|
STAT6 Transcription Factor
|
|
Concept
|
Receptors, Tumor Necrosis Factor
|
|
Concept
|
Receptors, Vascular Endothelial Growth Factor
|
|
Concept
|
Octamer Transcription Factor-2
|
|
Concept
|
Transcription Factor RelA
|
|
Academic Article
|
Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study.
|
|
Academic Article
|
Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
|
|
Academic Article
|
MYD88 L265P Mutation in Lymphoid Malignancies.
|
|
Academic Article
|
RelA NF-?B subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
|
|
Academic Article
|
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.
|
|
Academic Article
|
pSTAT3/pSTAT5 Signaling Patterns in Molecularly Defined Subsets of Myeloproliferative Neoplasms.
|
|
Academic Article
|
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
|
|
Academic Article
|
The SOX11-PDGFA axis in mantle cell lymphoma.
|
|
Academic Article
|
Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma.
|
|
Academic Article
|
PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin.
|
|
Academic Article
|
MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders.
|
|
Academic Article
|
Genetic heterogeneity of diffuse large B-cell lymphoma.
|
|
Academic Article
|
Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb.
|
|
Academic Article
|
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
|
|
Academic Article
|
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield.
|
|
Academic Article
|
Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
|
|
Academic Article
|
Microenvironment in peripheral T cell lymphomas: macrophages and angiogenesis as targets.
|
|
Academic Article
|
Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology.
|
|
Academic Article
|
UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation.
|
|
Academic Article
|
Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F.
|
|
Academic Article
|
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
|
|
Academic Article
|
Cytoplasmic localization of phosphorylated STAT5 in human acute myeloid leukemia is inversely correlated with Flt3-ITD.
|
|
Academic Article
|
Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation.
|
|
Academic Article
|
Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation.
|
|
Academic Article
|
T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6.
|
|
Academic Article
|
Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
|
|
Academic Article
|
Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.
|
|
Academic Article
|
Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival.
|
|
Academic Article
|
Latent membrane protein 1, tumor necrosis factor receptor-associated factor (TRAF) 1, TRAF-2, TRAF-3, and nuclear factor kappa B expression in posttransplantation lymphoproliferative disorders.
|
|
Academic Article
|
Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma.
|
|
Academic Article
|
Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
|
|
Academic Article
|
Rapid determination of cell-associated tumor necrosis factor production by flow cytometry.
|